Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Ronda Henry-Tillman

Concepts (256)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
39
2024
1206
4.620
 Why?
Early Detection of Cancer
6
2020
183
2.270
 Why?
Ultrasonography, Mammary
8
2020
61
1.980
 Why?
Mass Screening
3
2020
357
1.470
 Why?
Colorectal Neoplasms
4
2018
295
1.420
 Why?
Mastectomy
13
2019
143
1.050
 Why?
Healthcare Disparities
3
2017
299
1.040
 Why?
Mastectomy, Segmental
7
2018
92
1.030
 Why?
Sentinel Lymph Node Biopsy
10
2015
118
0.980
 Why?
Community Health Planning
3
2018
28
0.950
 Why?
Ultrasonography, Interventional
5
2020
138
0.820
 Why?
Biopsy, Needle
10
2015
182
0.810
 Why?
Focus Groups
1
2024
196
0.810
 Why?
Neoplasm Staging
14
2024
770
0.790
 Why?
Biopsy, Large-Core Needle
3
2020
33
0.790
 Why?
Female
55
2024
28105
0.740
 Why?
Genetic Counseling
1
2022
44
0.730
 Why?
Lymph Nodes
7
2015
252
0.730
 Why?
Neoplasms
5
2015
1305
0.720
 Why?
Health Status Disparities
3
2015
216
0.710
 Why?
Patient Education as Topic
1
2024
321
0.700
 Why?
Image Interpretation, Computer-Assisted
1
2020
97
0.660
 Why?
Image-Guided Biopsy
2
2020
34
0.630
 Why?
Middle Aged
40
2024
13014
0.630
 Why?
Hematoma
4
2018
65
0.620
 Why?
Surgery, Computer-Assisted
2
2018
53
0.620
 Why?
Polymorphism, Single Nucleotide
2
2018
506
0.600
 Why?
Humans
60
2024
52336
0.590
 Why?
Mandatory Programs
1
2018
22
0.580
 Why?
Adiposity
1
2019
143
0.560
 Why?
Faculty, Medical
3
2021
91
0.560
 Why?
Health Care Costs
1
2018
175
0.550
 Why?
Aged
31
2024
10109
0.530
 Why?
Adult
32
2024
14139
0.530
 Why?
Insurance Coverage
1
2018
115
0.520
 Why?
Disease Management
1
2018
188
0.510
 Why?
Diagnostic Imaging
1
2018
174
0.510
 Why?
Minority Groups
3
2015
135
0.500
 Why?
Arkansas
9
2018
2028
0.480
 Why?
Retrospective Studies
19
2022
6578
0.460
 Why?
Physicians
1
2018
240
0.450
 Why?
Health Planning Councils
1
2014
6
0.440
 Why?
Community-Based Participatory Research
2
2015
204
0.420
 Why?
Health Policy
1
2014
158
0.400
 Why?
Rural Population
1
2017
572
0.400
 Why?
Follow-Up Studies
11
2018
2268
0.390
 Why?
Aged, 80 and over
14
2018
3391
0.380
 Why?
Qualitative Research
3
2024
362
0.380
 Why?
Community Networks
2
2015
50
0.370
 Why?
Community-Institutional Relations
1
2011
46
0.370
 Why?
Primary Health Care
2
2024
375
0.370
 Why?
Carcinoma, Ductal, Breast
4
2015
89
0.360
 Why?
Carcinoma, Lobular
2
2015
32
0.360
 Why?
Population Surveillance
1
2012
165
0.350
 Why?
Physicians, Women
2
2021
21
0.340
 Why?
Neoplasm Recurrence, Local
6
2014
643
0.330
 Why?
Women's Health
1
2010
82
0.320
 Why?
Health Education
2
2008
156
0.320
 Why?
Needs Assessment
2
2024
139
0.310
 Why?
Medical Oncology
1
2010
104
0.310
 Why?
Breast Diseases
4
2018
25
0.300
 Why?
Schools, Medical
2
2020
68
0.280
 Why?
Nipples
5
2013
33
0.280
 Why?
Axilla
6
2015
92
0.280
 Why?
Health Knowledge, Attitudes, Practice
1
2012
509
0.280
 Why?
Socioeconomic Factors
3
2018
606
0.270
 Why?
Morbidity
2
2018
141
0.270
 Why?
Physician-Patient Relations
2
2012
144
0.260
 Why?
Health Services Accessibility
1
2011
437
0.260
 Why?
Catheter Ablation
4
2014
125
0.250
 Why?
Mammaplasty
3
2013
43
0.250
 Why?
Lymphatic Metastasis
7
2015
212
0.240
 Why?
Mentors
1
2006
57
0.240
 Why?
Prognosis
9
2024
2094
0.240
 Why?
Survivors
2
2024
118
0.240
 Why?
Occult Blood
2
2017
23
0.230
 Why?
United States
7
2022
5182
0.220
 Why?
Young Adult
5
2024
4319
0.220
 Why?
Magnetic Resonance Imaging
5
2014
1543
0.220
 Why?
Referral and Consultation
2
2024
292
0.210
 Why?
Education, Medical, Graduate
2
2022
220
0.200
 Why?
Technetium Tc 99m Sulfur Colloid
4
2008
31
0.200
 Why?
Empathy
1
2002
47
0.190
 Why?
Male
13
2022
26696
0.190
 Why?
Problem-Based Learning
1
2002
50
0.190
 Why?
Emotions
1
2023
174
0.180
 Why?
Atrial Fibrillation
1
2024
200
0.180
 Why?
Breast
2
2020
85
0.180
 Why?
Democratic Republic of the Congo
1
2020
4
0.180
 Why?
Genetic Testing
1
2022
130
0.180
 Why?
Dermatologic Surgical Procedures
3
2013
35
0.180
 Why?
Counseling
1
2022
136
0.180
 Why?
Combined Modality Therapy
4
2018
636
0.180
 Why?
Feasibility Studies
2
2020
402
0.170
 Why?
Biopsy, Fine-Needle
1
2020
107
0.170
 Why?
Research Support as Topic
1
2020
44
0.170
 Why?
Students, Medical
1
2002
159
0.160
 Why?
General Surgery
1
2021
106
0.160
 Why?
Surgical Flaps
2
2019
110
0.160
 Why?
Obesity
1
2008
1162
0.160
 Why?
Prospective Studies
10
2024
2428
0.160
 Why?
Incidence
2
2024
1059
0.150
 Why?
Patient Satisfaction
2
2019
284
0.150
 Why?
Radiopharmaceuticals
4
2008
205
0.140
 Why?
Adipose Tissue
1
2019
204
0.140
 Why?
Logistic Models
2
2018
920
0.140
 Why?
Diagnosis, Differential
1
2020
1044
0.140
 Why?
Lymphatic Vessels
2
2008
44
0.130
 Why?
Rural Health
1
2017
88
0.130
 Why?
Odds Ratio
1
2018
558
0.130
 Why?
Internship and Residency
1
2022
449
0.130
 Why?
Zambia
3
2024
3
0.130
 Why?
Mammography
1
2016
97
0.130
 Why?
Rural Health Services
1
2018
169
0.120
 Why?
Cytodiagnosis
2
2013
43
0.120
 Why?
Genetic Predisposition to Disease
1
2018
528
0.120
 Why?
Case-Control Studies
1
2018
1201
0.120
 Why?
Risk Assessment
2
2018
1323
0.120
 Why?
Cross-Sectional Studies
3
2021
1676
0.120
 Why?
National Cancer Institute (U.S.)
1
2015
33
0.120
 Why?
Survival Rate
1
2017
940
0.110
 Why?
Uterine Cervical Neoplasms
1
2017
299
0.110
 Why?
Algorithms
1
2018
668
0.110
 Why?
Career Mobility
2
2021
29
0.110
 Why?
Patient Care Planning
1
2013
68
0.100
 Why?
Carcinoma, Intraductal, Noninfiltrating
1
2013
46
0.100
 Why?
Monitoring, Intraoperative
3
2014
54
0.100
 Why?
Education, Medical
2
2006
111
0.100
 Why?
Sigmoidoscopy
1
2012
10
0.100
 Why?
Reagent Kits, Diagnostic
1
2012
17
0.100
 Why?
Health Services
1
2012
65
0.090
 Why?
Lymph Node Excision
4
2008
133
0.090
 Why?
Reproducibility of Results
1
2015
1214
0.090
 Why?
Colonoscopy
1
2012
108
0.090
 Why?
Treatment Outcome
9
2017
5407
0.090
 Why?
Receptors, Estrogen
2
2015
132
0.090
 Why?
Feces
1
2012
154
0.090
 Why?
Pancreatic Neoplasms
1
2013
214
0.090
 Why?
Lymphedema
2
2008
48
0.090
 Why?
Fructose
1
2010
22
0.090
 Why?
Clinical Competence
1
2013
404
0.090
 Why?
Patient Compliance
1
2012
230
0.080
 Why?
Carbon
1
2010
55
0.080
 Why?
Registries
1
2013
580
0.080
 Why?
History, 21st Century
1
2010
59
0.080
 Why?
Risk Factors
3
2024
3872
0.080
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1031
0.080
 Why?
Carcinoma in Situ
2
2006
72
0.080
 Why?
Patient Acceptance of Health Care
1
2012
355
0.070
 Why?
Delivery of Health Care
1
2011
323
0.070
 Why?
Models, Theoretical
2
2006
182
0.070
 Why?
Prochlorperazine
1
2006
6
0.060
 Why?
Postoperative Nausea and Vomiting
1
2006
20
0.060
 Why?
Sensitivity and Specificity
3
2004
879
0.060
 Why?
Antiemetics
1
2006
32
0.060
 Why?
Education, Medical, Continuing
1
2006
72
0.060
 Why?
Receptor, erbB-2
1
2006
80
0.060
 Why?
Body Weights and Measures
1
2005
17
0.060
 Why?
Biopsy
2
2004
604
0.060
 Why?
Predictive Value of Tests
2
2013
943
0.060
 Why?
Intraoperative Care
2
2003
51
0.060
 Why?
Gadolinium
1
2005
44
0.060
 Why?
Interprofessional Relations
1
2006
91
0.060
 Why?
Tissue Expansion Devices
1
2004
3
0.060
 Why?
Neuromuscular Agents
1
2004
8
0.060
 Why?
Neoadjuvant Therapy
2
2017
125
0.060
 Why?
Botulinum Toxins, Type A
1
2004
14
0.060
 Why?
Imaging, Three-Dimensional
1
2005
150
0.060
 Why?
Contrast Media
1
2005
174
0.060
 Why?
Life Expectancy
1
2024
34
0.050
 Why?
Cytological Techniques
1
2003
13
0.050
 Why?
Anthracyclines
1
2024
32
0.050
 Why?
Neoplasm Grading
2
2014
126
0.050
 Why?
Neoplasms, Multiple Primary
1
2003
44
0.050
 Why?
Pain, Postoperative
1
2004
169
0.050
 Why?
Preoperative Care
3
2014
172
0.050
 Why?
Surgical Instruments
1
2002
28
0.050
 Why?
Foreign-Body Migration
1
2002
31
0.050
 Why?
Humanism
1
2002
8
0.050
 Why?
Life Change Events
1
2002
36
0.050
 Why?
Confidence Intervals
1
2002
158
0.050
 Why?
Program Development
1
2002
165
0.050
 Why?
Career Choice
1
2002
116
0.050
 Why?
Sexism
1
2021
11
0.050
 Why?
Image Processing, Computer-Assisted
1
2002
247
0.040
 Why?
Leadership
1
2021
104
0.040
 Why?
Neoplasm Invasiveness
2
2010
278
0.040
 Why?
Vacuum
2
2011
11
0.040
 Why?
Curriculum
1
2002
399
0.040
 Why?
Stereotaxic Techniques
2
2010
40
0.040
 Why?
Angiopoietin-2
1
2017
14
0.030
 Why?
Angiopoietin-1
1
2017
16
0.030
 Why?
Receptor, TIE-2
1
2017
16
0.030
 Why?
Fibroblast Growth Factor 2
1
2017
35
0.030
 Why?
Clinical Trials, Phase II as Topic
1
2017
47
0.030
 Why?
Gene Frequency
1
2017
99
0.030
 Why?
Injections, Intralesional
2
2008
31
0.030
 Why?
Matrix Metalloproteinase 9
1
2017
87
0.030
 Why?
Adolescent
3
2013
6692
0.030
 Why?
Guidelines as Topic
1
2016
110
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
186
0.030
 Why?
Regression Analysis
1
2017
401
0.030
 Why?
Neovascularization, Pathologic
1
2017
158
0.030
 Why?
Coloring Agents
2
2007
68
0.030
 Why?
Radionuclide Imaging
2
2007
107
0.030
 Why?
Educational Status
1
2016
227
0.030
 Why?
Genotype
1
2017
569
0.030
 Why?
Taxoids
1
2015
37
0.030
 Why?
Receptors, Progesterone
1
2015
66
0.030
 Why?
Cohort Studies
2
2011
1532
0.030
 Why?
Cyclophosphamide
1
2015
171
0.030
 Why?
Touch
1
2013
24
0.030
 Why?
Ultrasonography, Doppler
1
2014
42
0.030
 Why?
Carcinoma
1
2015
137
0.030
 Why?
Angiogenesis Inhibitors
1
2015
183
0.030
 Why?
Antibodies, Monoclonal, Humanized
1
2015
236
0.030
 Why?
Disease-Free Survival
1
2014
460
0.030
 Why?
Kaplan-Meier Estimate
1
2014
484
0.020
 Why?
Cicatrix
1
2011
42
0.020
 Why?
Microscopy, Phase-Contrast
1
2010
11
0.020
 Why?
Plant Lectins
1
2010
8
0.020
 Why?
Glycosylation
1
2010
106
0.020
 Why?
Substrate Specificity
1
2010
198
0.020
 Why?
Actins
1
2010
117
0.020
 Why?
Tumor Cells, Cultured
1
2010
456
0.020
 Why?
Cell Movement
1
2010
277
0.020
 Why?
Breast Neoplasms, Male
1
2009
6
0.020
 Why?
Pilot Projects
1
2011
719
0.020
 Why?
Arm
1
2008
47
0.020
 Why?
Phenotype
1
2010
799
0.020
 Why?
Cost-Benefit Analysis
1
2008
269
0.020
 Why?
Administration, Rectal
1
2006
8
0.020
 Why?
Positron-Emission Tomography
1
2008
303
0.020
 Why?
Cell Line, Tumor
1
2010
1436
0.020
 Why?
Primary Prevention
1
2006
45
0.020
 Why?
Probability
1
2006
171
0.020
 Why?
Drug Administration Schedule
1
2006
372
0.020
 Why?
Carcinoma, Ductal
1
2004
7
0.010
 Why?
Administration, Oral
1
2006
451
0.010
 Why?
Tissue Expansion
1
2004
4
0.010
 Why?
Pectoralis Muscles
1
2004
6
0.010
 Why?
Rectus Abdominis
1
2004
10
0.010
 Why?
Spasm
1
2004
9
0.010
 Why?
Multivariate Analysis
1
2006
590
0.010
 Why?
Laser Coagulation
1
2004
27
0.010
 Why?
Cryosurgery
1
2004
36
0.010
 Why?
Sampling Studies
1
2004
38
0.010
 Why?
Statistics, Nonparametric
1
2004
192
0.010
 Why?
Chi-Square Distribution
1
2004
288
0.010
 Why?
Injections
1
2003
61
0.010
 Why?
Pain Measurement
1
2004
257
0.010
 Why?
Ultrasonography
1
2004
424
0.010
 Why?
Dose-Response Relationship, Drug
1
2006
1377
0.010
 Why?
Length of Stay
1
2004
659
0.010
 Why?
Reoperation
1
2002
465
0.010
 Why?
Analgesics, Opioid
1
2004
590
0.010
 Why?
Henry-Tillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (256) concept(s)
_
Co-Authors Expand Description
See all (27) people
_
Similar People Expand Description
See all (31) people
_
Same Department Expand Description
Search Department